| M.k. Hamza Ph.d., P.a. | |
|
2300 Highway 365 Ste 110 Nederland TX 77627-6256 | |
| (409) 729-0400 | |
| (409) 729-0453 |
| Full Name | M.k. Hamza Ph.d., P.a. |
|---|---|
| Speciality | Psychologist |
| Location | 2300 Highway 365, Nederland, Texas |
| Authorized Official Name and Position | M.k. Hamza (OWNER) |
| Authorized Official Contact | 4097290400 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| M.k. Hamza Ph.d., P.a. 2300 Highway 365 Ste 110 Nederland TX 77627-6256 Ph: (409) 729-0400 | M.k. Hamza Ph.d., P.a. 2300 Highway 365 Ste 110 Nederland TX 77627-6256 Ph: (409) 729-0400 |
| NPI Number | 1346434750 |
|---|---|
| Provider Enumeration Date | 08/29/2007 |
| Last Update Date | 10/20/2008 |
| Medicare PECOS PAC ID | 3072607431 |
|---|---|
| Medicare Enrollment ID | O20070926001133 |
News Archive
Most patients with an inherited heart condition known as arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) don't know they have a problem until they're in their early 20s. The lack of symptoms at younger ages makes it very difficult for researchers to study how ARVD/C evolves or to develop treatments. A new stem cell-based technology created by 2012 Nobel Prize winner Shinya Yamanaka, M.D., Ph.D., helps solve this problem.
The American Academy of Pediatric Dentistry today announces the launch of its Head Start Dental Home Initiative to benefit the one-in-three low-income children in the state of Illinois. The Initiative links children participating in Head Start programs to local dentists who will provide children with a "dental home" which will ensure that each child's oral health care is delivered in a comprehensive, ongoing, accessible, coordinated and family-centered way by a participating dentist.
State policies to ensure drug selection in Medicaid programs is free from outside influence vary widely, according to a new study.
Intarcia Therapeutics, Inc. today announced the start of enrollment for a phase 2 study comparing its proprietary drug candidate ITCA 650 (DUROS continuous delivery of exenatide) with Byetta, an FDA-approved twice-daily injection form of exenatide.
A protocol that uses continuous real-time radiation monitoring, low-dose imaging programs and requires physician awareness of radiation dose, significantly reduced radiation exposure during electrophysiology procedures and catheter ablations to diagnose and treat heart arrhythmias in children, according to research presented at the American Heart Association's Scientific Sessions 2010.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346434750 | NPI | - | NPPES |
| 185694001 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 33373 (Texas) | Primary |
| 103TC2200X | Psychologist - Clinical Child & Adolescent | 33373 (Texas) | Secondary |
| Provider Name | Mohammad K Hamza |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1487860425 PECOS PAC ID: 8729179411 Enrollment ID: I20070809000625 |
News Archive
Most patients with an inherited heart condition known as arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) don't know they have a problem until they're in their early 20s. The lack of symptoms at younger ages makes it very difficult for researchers to study how ARVD/C evolves or to develop treatments. A new stem cell-based technology created by 2012 Nobel Prize winner Shinya Yamanaka, M.D., Ph.D., helps solve this problem.
The American Academy of Pediatric Dentistry today announces the launch of its Head Start Dental Home Initiative to benefit the one-in-three low-income children in the state of Illinois. The Initiative links children participating in Head Start programs to local dentists who will provide children with a "dental home" which will ensure that each child's oral health care is delivered in a comprehensive, ongoing, accessible, coordinated and family-centered way by a participating dentist.
State policies to ensure drug selection in Medicaid programs is free from outside influence vary widely, according to a new study.
Intarcia Therapeutics, Inc. today announced the start of enrollment for a phase 2 study comparing its proprietary drug candidate ITCA 650 (DUROS continuous delivery of exenatide) with Byetta, an FDA-approved twice-daily injection form of exenatide.
A protocol that uses continuous real-time radiation monitoring, low-dose imaging programs and requires physician awareness of radiation dose, significantly reduced radiation exposure during electrophysiology procedures and catheter ablations to diagnose and treat heart arrhythmias in children, according to research presented at the American Heart Association's Scientific Sessions 2010.
› Verified 8 days ago
News Archive
Most patients with an inherited heart condition known as arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) don't know they have a problem until they're in their early 20s. The lack of symptoms at younger ages makes it very difficult for researchers to study how ARVD/C evolves or to develop treatments. A new stem cell-based technology created by 2012 Nobel Prize winner Shinya Yamanaka, M.D., Ph.D., helps solve this problem.
The American Academy of Pediatric Dentistry today announces the launch of its Head Start Dental Home Initiative to benefit the one-in-three low-income children in the state of Illinois. The Initiative links children participating in Head Start programs to local dentists who will provide children with a "dental home" which will ensure that each child's oral health care is delivered in a comprehensive, ongoing, accessible, coordinated and family-centered way by a participating dentist.
State policies to ensure drug selection in Medicaid programs is free from outside influence vary widely, according to a new study.
Intarcia Therapeutics, Inc. today announced the start of enrollment for a phase 2 study comparing its proprietary drug candidate ITCA 650 (DUROS continuous delivery of exenatide) with Byetta, an FDA-approved twice-daily injection form of exenatide.
A protocol that uses continuous real-time radiation monitoring, low-dose imaging programs and requires physician awareness of radiation dose, significantly reduced radiation exposure during electrophysiology procedures and catheter ablations to diagnose and treat heart arrhythmias in children, according to research presented at the American Heart Association's Scientific Sessions 2010.
› Verified 8 days ago
Clinical Social Work Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3005 Avenue H, Nederland, TX 77627 Phone: 409-724-1920 Fax: 409-724-1102 | |
Victor M. Fermo Jr., Md Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 405 S Memorial Fwy, Nederland, TX 77627 Phone: 409-727-7979 Fax: 409-727-5459 | |
Turning Point Changing Lives L.l.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 409 S Highway 69, Nederland, TX 77627 Phone: 709-727-6468 Fax: 409-727-6488 | |
C & M Geriatric Services Llp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2300 Highway 365, Suite 110, Nederland, TX 77627 Phone: 409-729-0400 Fax: 866-573-8008 | |
Vision Psychological Services Llp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2300 Highway 365, 110, Nederland, TX 77627 Phone: 409-729-0400 Fax: 409-729-0453 | |
Kyler Counseling Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 320 N. 12th St., Nederland, TX 77627 Phone: 409-344-3074 |